Ultragenyx Pharmaceutical Inc. buy TD Cowen
Start price
24.04.24
/
50%
€41.20
Target price
24.04.25
€57.02
Performance (%)
-20.39%
End price
25.04.25
€32.80
Summary
This prediction ended on 25.04.25 with a price of €32.80. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.39%. TD_Cowen has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 5.036% | 5.036% | -29.808% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
Comments by TD_Cowen for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at TD Cowen from $59.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten
Current prediction by TD_Cowen for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€27.80
05.11.25
05.11.25
€65.26
05.11.26
05.11.26
4.32%
23.12.25
23.12.25
Stopped prediction by TD_Cowen for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.00
21.10.24
21.10.24
€67.47
21.10.25
21.10.25
-41.20%
22.10.25
22.10.25